Lv31
250 积分 2021-10-26 加入
Efficacy and safety of methotrexate, omalizumab and dupilumab for bullous pemphigoid in patients resistant or contraindicated to oral steroids. A monocentric real‐life study
1小时前
待确认
A retrospective case series of 20 patients with immunotherapy-induced bullous pemphigoid with emphasis on management outcomes
2小时前
已完结
Dupilumab in Children Under 6 Years With Moderate‐to‐Severe Atopic Dermatitis: A 16‐Week Real‐World Prospective Study on Efficacy, Safety, and Local‐Systemic Immune Responses
3小时前
已完结
Double Dose of Dupilumab Shows Efficacy in Treatment-Resistant Bullous Pemphigoid
29天前
已完结
A decade of gliptin‐induced bullous pemphigoid
29天前
已完结
Serum inflammatory biomarkers associated with disease severity and response to dupilumab treatment in bullous pemphigoid: a cluster analysis
1个月前
已完结
Efficacy and safety of methotrexate, omalizumab and dupilumab for bullous pemphigoid in patients resistant or contraindicated to oral steroids. A monocentric real‐life study
3个月前
已完结
Symptomatic Dermographism: A Systematic Review of Treatment Options
3个月前
已关闭
The efficacy and safety of dupilumab combined with methylprednisolone in the treatment of bullous pemphigoid in China
3个月前
已完结
Dupilumab as a novel therapy for bullous pemphigoid
3个月前
已完结
皖公网安备34019202002308
